Drug Information

Drug General Information
Drug ID
D00HVX
Former ID
DNC005878
Drug Name
[1,2,4]triazolo[1,5-a]quinoxalin-4(5H)-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527915]
Formula
C9H6N4O
Canonical SMILES
C1=CC=C2C(=C1)NC(=O)C3=NC=NN23
InChI
1S/C9H6N4O/c14-9-8-10-5-11-13(8)7-4-2-1-3-6(7)12-9/h1-5H,(H,12,14)
InChIKey
OEIMIUHARCZWJY-UHFFFAOYSA-N
PubChem Compound ID
10103893
Target and Pathway
Target(s) Adenosine A3 receptor Target Info Inhibitor [527915]
Reactome Adenosine P1 receptors
G alpha (i) signalling events
WikiPathways Nucleotide GPCRs
GPCRs, Class A Rhodopsin-like
GPCRs, Other
References
Ref 527915J Med Chem. 2005 Dec 15;48(25):7932-45.1,2,4-Triazolo[1,5-a]quinoxaline as a versatile tool for the design of selective human A3 adenosine receptor antagonists: synthesis, biological evaluation, and molecular modeling studies of 2-(hetero)aryl- and 2-carboxy-substituted derivatives.
Ref 527915J Med Chem. 2005 Dec 15;48(25):7932-45.1,2,4-Triazolo[1,5-a]quinoxaline as a versatile tool for the design of selective human A3 adenosine receptor antagonists: synthesis, biological evaluation, and molecular modeling studies of 2-(hetero)aryl- and 2-carboxy-substituted derivatives.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.